FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016488051> ?p ?o ?g. }

• W3016488051 endingPage "7" @default.
• W3016488051 startingPage "1" @default.
• W3016488051 abstract "To determine the risk factors of nonadherence to azathioprine (AZA) maintenance therapy for Crohn's disease (CD) and to evaluate the influence of patients' educational program on adherence to AZA maintenance therapy.Patients receiving AZA as maintenance therapy for CD were enrolled. Demographic data, clinical data, and usage information were collected. Univariate and multivariate analyses were performed to identify the risk factors of nonadherence. Then, patients' educational program was conducted. One year after the program, the improvements in adherence and relapse rates were compared between educational and noneducational groups.A total of 378 CD patients receiving AZA as maintenance therapy were enrolled from September 2008 to September 2018. Nonadherence occurred in 43.9% (166/378) of patients. Univariate analysis revealed that young age, education, alcoholism, anxiety, depression, concern belief, and lack of necessity belief and AZA knowledge were risk factors of nonadherence (P < 0.05). Multivariate logistic regression showed that anxiety (OR 6.244, 95% CI 2.563-15.213), depression (OR 3.801, 95% CI 1.281-11.278), and concern belief (OR 19.531, 95% CI 3.393-120.732) were independent risk factors of nonadherence. Necessity belief (OR 0.961, 95% CI 0.925-0.999) and AZA knowledge (OR 0.823, 95% CI 0.758-0.903) were protective factors of adherence. One year after the AZA educational program, the necessity belief, AZA knowledge, and adherence of the educational group significantly improved (P < 0.05). Concern belief was significantly lower in the educational group than that in the noneducational group (P < 0.05). Moreover, the noneducational group suffered significantly higher endoscopic relapse rates than that the educational group (15.9% vs. 30.1%, P = 0.035).Nonadherence occurred frequently in CD patients receiving AZA maintenance therapy. Educational programs could improve patients' adherence mainly by promoting their beliefs and knowledge of AZA and could reduce relapse rates during treatment." @default.
• W3016488051 created "2020-04-24" @default.
• W3016488051 creator A5034855502 @default.
• W3016488051 creator A5035755412 @default.
• W3016488051 creator A5038601803 @default.
• W3016488051 creator A5066738831 @default.
• W3016488051 creator A5073216396 @default.
• W3016488051 creator A5080132424 @default.
• W3016488051 creator A5083245892 @default.
• W3016488051 date "2020-04-20" @default.
• W3016488051 modified "2023-10-16" @default.
• W3016488051 title "Patients’ Educational Program Could Improve Azathioprine Adherence in Crohn’s Disease Maintenance Therapy" @default.
• W3016488051 cites W1590601985 @default.
• W3016488051 cites W1813734486 @default.
• W3016488051 cites W1974110731 @default.
• W3016488051 cites W1983008512 @default.
• W3016488051 cites W199610504 @default.
• W3016488051 cites W2023743179 @default.
• W3016488051 cites W2030975937 @default.
• W3016488051 cites W2036529637 @default.
• W3016488051 cites W2037945988 @default.
• W3016488051 cites W2038795551 @default.
• W3016488051 cites W2055894754 @default.
• W3016488051 cites W2071662837 @default.
• W3016488051 cites W2085273394 @default.
• W3016488051 cites W2102087425 @default.
• W3016488051 cites W2107089018 @default.
• W3016488051 cites W2110286478 @default.
• W3016488051 cites W2112157563 @default.
• W3016488051 cites W2151634683 @default.
• W3016488051 cites W2156250460 @default.
• W3016488051 cites W2200524351 @default.
• W3016488051 cites W2523706394 @default.
• W3016488051 cites W2552501332 @default.
• W3016488051 cites W2577611680 @default.
• W3016488051 cites W2597284704 @default.
• W3016488051 cites W2766046358 @default.
• W3016488051 cites W2920988924 @default.
• W3016488051 cites W2946230476 @default.
• W3016488051 cites W4231630787 @default.
• W3016488051 doi "https://doi.org/10.1155/2020/6848293" @default.
• W3016488051 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7189306" @default.
• W3016488051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32382270" @default.
• W3016488051 hasPublicationYear "2020" @default.
• W3016488051 type Work @default.
• W3016488051 sameAs 3016488051 @default.
• W3016488051 citedByCount "2" @default.
• W3016488051 countsByYear W30164880512021 @default.
• W3016488051 countsByYear W30164880512023 @default.
• W3016488051 crossrefType "journal-article" @default.
• W3016488051 hasAuthorship W3016488051A5034855502 @default.
• W3016488051 hasAuthorship W3016488051A5035755412 @default.
• W3016488051 hasAuthorship W3016488051A5038601803 @default.
• W3016488051 hasAuthorship W3016488051A5066738831 @default.
• W3016488051 hasAuthorship W3016488051A5073216396 @default.
• W3016488051 hasAuthorship W3016488051A5080132424 @default.
• W3016488051 hasAuthorship W3016488051A5083245892 @default.
• W3016488051 hasBestOaLocation W30164880511 @default.
• W3016488051 hasConcept C105795698 @default.
• W3016488051 hasConcept C118552586 @default.
• W3016488051 hasConcept C126322002 @default.
• W3016488051 hasConcept C139719470 @default.
• W3016488051 hasConcept C144301174 @default.
• W3016488051 hasConcept C151956035 @default.
• W3016488051 hasConcept C161584116 @default.
• W3016488051 hasConcept C162324750 @default.
• W3016488051 hasConcept C199163554 @default.
• W3016488051 hasConcept C2776694085 @default.
• W3016488051 hasConcept C2776760755 @default.
• W3016488051 hasConcept C2776867660 @default.
• W3016488051 hasConcept C2778283404 @default.
• W3016488051 hasConcept C2779134260 @default.
• W3016488051 hasConcept C33923547 @default.
• W3016488051 hasConcept C38180746 @default.
• W3016488051 hasConcept C558461103 @default.
• W3016488051 hasConcept C71924100 @default.
• W3016488051 hasConceptScore W3016488051C105795698 @default.
• W3016488051 hasConceptScore W3016488051C118552586 @default.
• W3016488051 hasConceptScore W3016488051C126322002 @default.
• W3016488051 hasConceptScore W3016488051C139719470 @default.
• W3016488051 hasConceptScore W3016488051C144301174 @default.
• W3016488051 hasConceptScore W3016488051C151956035 @default.
• W3016488051 hasConceptScore W3016488051C161584116 @default.
• W3016488051 hasConceptScore W3016488051C162324750 @default.
• W3016488051 hasConceptScore W3016488051C199163554 @default.
• W3016488051 hasConceptScore W3016488051C2776694085 @default.
• W3016488051 hasConceptScore W3016488051C2776760755 @default.
• W3016488051 hasConceptScore W3016488051C2776867660 @default.
• W3016488051 hasConceptScore W3016488051C2778283404 @default.
• W3016488051 hasConceptScore W3016488051C2779134260 @default.
• W3016488051 hasConceptScore W3016488051C33923547 @default.
• W3016488051 hasConceptScore W3016488051C38180746 @default.
• W3016488051 hasConceptScore W3016488051C558461103 @default.
• W3016488051 hasConceptScore W3016488051C71924100 @default.
• W3016488051 hasFunder F4320321885 @default.
• W3016488051 hasLocation W30164880511 @default.
• W3016488051 hasLocation W30164880512 @default.
• W3016488051 hasLocation W30164880513 @default.

• next